FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386278311> ?p ?o ?g. }

• W4386278311 abstract "<h3>Topical calcineurin inhibitors in cutaneous lupus erythematosus</h3> In the management of cutaneous lupus erythematosus (CLE), topical calcineurin inhibitors have recently been established as the first-line treatment according to the S2k guidelines for the treatment of CLE.^{1 2} This recommendation is further supported by the 2019 European League Against Rheumatism (EULAR) recommendations, which state that topical calcineurin inhibitors should be considered as a primary choice for treating cutaneous lesions in patients with systemic lupus erythematosus (SLE).³ A randomized, controlled trial demonstrated tacrolimus 0.1% ointment to be significantly more effective than placebo in treating CLE.⁴ Additionally, facial lesions showed a better response to tacrolimus ointment 0.1% compared to lesions on the body, particularly when the lesions had been present for less than 6 months. In summary, tacrolimus ointment 0.1% is recommended primarily for treating facial lesions in CLE and can serve as an alternative to topical glucocorticoids. In cases where the disease is widespread and/or there is a risk of scarring, concurrent treatment with antimalarials is recommended. <h3>Case: A 34-year-old female with SLE</h3> A 34-year-old female patient diagnosed with SLE presented with confluent erythematous, edematous papules and plaques, known as ’malar rash’, on the left side of her face. She received treatment with antimalarial agents and mycophenolate mofetil; however, over the past month, she had developed skin lesions after sun exposure. After 28 days of treatment with tacrolimus ointment 0.1%, her skin lesions had completely resolved. No recurrence of skin lesions was observed after 84 days of treatment with 0.1% tacrolimus ointment.⁴ <h3>References</h3> Kuhn A, <i>et al</i>. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). <i>J Eur Acad Dermatol Venereol</i>. 2017 Mar;<b>31</b>(3):389–404. doi: 10.1111/jdv.14053. Worm M, <i>et al.</i> S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 2: Therapy, risk factors and other special topics. <i>J Dtsch Dermatol Ges</i>. 2021 Sep;<b>19</b>(9):1371–1395. doi: 10.1111/ddg.14491. Fanouriakis A, <i>et al.</i> 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. <i>Ann Rheum Dis</i>. 2019 Jun;<b>78</b>(6):736–745. doi: 10.1136/annrheumdis-2019-215089. Kuhn A, <i>et al.</i> Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial. <i>J Am Acad Dermatol</i>. 2011 Jul;<b>65</b>(1):54–64, 64.e1-2. doi: 10.1016/j.jaad.2010.03.037. <h3>Learning Objectives</h3> Discuss the topical and systemic treatment options in CLE Describe the preventive strategies in CLE Discuss the therapeutic guidelines of CLE Describe the RCLASI as validated activity and damage score of CLE" @default.
• W4386278311 created "2023-08-31" @default.
• W4386278311 creator A5005845348 @default.
• W4386278311 date "2023-08-30" @default.
• W4386278311 modified "2023-09-27" @default.
• W4386278311 title "20 Management of skin involvement in SLE" @default.
• W4386278311 doi "https://doi.org/10.1136/lupus-2023-la.20" @default.
• W4386278311 hasPublicationYear "2023" @default.
• W4386278311 type Work @default.
• W4386278311 citedByCount "0" @default.
• W4386278311 crossrefType "proceedings-article" @default.
• W4386278311 hasAuthorship W4386278311A5005845348 @default.
• W4386278311 hasBestOaLocation W43862783111 @default.
• W4386278311 hasConcept C126322002 @default.
• W4386278311 hasConcept C128057223 @default.
• W4386278311 hasConcept C141071460 @default.
• W4386278311 hasConcept C149443304 @default.
• W4386278311 hasConcept C159654299 @default.
• W4386278311 hasConcept C16005928 @default.
• W4386278311 hasConcept C163764329 @default.
• W4386278311 hasConcept C203014093 @default.
• W4386278311 hasConcept C2775915377 @default.
• W4386278311 hasConcept C2776028589 @default.
• W4386278311 hasConcept C2776670291 @default.
• W4386278311 hasConcept C2776748653 @default.
• W4386278311 hasConcept C2776912625 @default.
• W4386278311 hasConcept C2777165109 @default.
• W4386278311 hasConcept C2777761306 @default.
• W4386278311 hasConcept C2779075594 @default.
• W4386278311 hasConcept C2779134260 @default.
• W4386278311 hasConcept C2909675724 @default.
• W4386278311 hasConcept C2911091166 @default.
• W4386278311 hasConcept C2911091503 @default.
• W4386278311 hasConcept C71924100 @default.
• W4386278311 hasConceptScore W4386278311C126322002 @default.
• W4386278311 hasConceptScore W4386278311C128057223 @default.
• W4386278311 hasConceptScore W4386278311C141071460 @default.
• W4386278311 hasConceptScore W4386278311C149443304 @default.
• W4386278311 hasConceptScore W4386278311C159654299 @default.
• W4386278311 hasConceptScore W4386278311C16005928 @default.
• W4386278311 hasConceptScore W4386278311C163764329 @default.
• W4386278311 hasConceptScore W4386278311C203014093 @default.
• W4386278311 hasConceptScore W4386278311C2775915377 @default.
• W4386278311 hasConceptScore W4386278311C2776028589 @default.
• W4386278311 hasConceptScore W4386278311C2776670291 @default.
• W4386278311 hasConceptScore W4386278311C2776748653 @default.
• W4386278311 hasConceptScore W4386278311C2776912625 @default.
• W4386278311 hasConceptScore W4386278311C2777165109 @default.
• W4386278311 hasConceptScore W4386278311C2777761306 @default.
• W4386278311 hasConceptScore W4386278311C2779075594 @default.
• W4386278311 hasConceptScore W4386278311C2779134260 @default.
• W4386278311 hasConceptScore W4386278311C2909675724 @default.
• W4386278311 hasConceptScore W4386278311C2911091166 @default.
• W4386278311 hasConceptScore W4386278311C2911091503 @default.
• W4386278311 hasConceptScore W4386278311C71924100 @default.
• W4386278311 hasLocation W43862783111 @default.
• W4386278311 hasOpenAccess W4386278311 @default.
• W4386278311 hasPrimaryLocation W43862783111 @default.
• W4386278311 hasRelatedWork W1555543815 @default.
• W4386278311 hasRelatedWork W1992222699 @default.
• W4386278311 hasRelatedWork W2036170885 @default.
• W4386278311 hasRelatedWork W2095547271 @default.
• W4386278311 hasRelatedWork W2154819769 @default.
• W4386278311 hasRelatedWork W2166764883 @default.
• W4386278311 hasRelatedWork W2419478427 @default.
• W4386278311 hasRelatedWork W2922354564 @default.
• W4386278311 hasRelatedWork W4362554200 @default.
• W4386278311 hasRelatedWork W4386278311 @default.
• W4386278311 isParatext "false" @default.
• W4386278311 isRetracted "false" @default.
• W4386278311 workType "article" @default.